Navigation Links
Hepatitis B Foundation to Host Annual Crystal Ball Gala
Date:1/14/2014

Doylestown, PA (PRWEB) January 14, 2014

Date: Friday, April 11, 2014

Time: 6 p.m. – 11 p.m.

Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa.

Details: The Hepatitis B Foundation, the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide, will host its annual Crystal Ball on Friday, April 11 at Warrington Country Club in Warrington, Pa.

Each year, the Crystal Ball attracts hundreds of leaders from the community, academic institutions, government, health care industry and biotech executives. The gala evening is a fundraiser for the foundation, with all proceeds benefitting its global research, outreach and patient advocacy programs.

This year’s event, the “Cherry Blossom Extravaganza,” includes an evening of dinner, dancing, a silent auction and awards ceremony. The Foundation will honor Dr. Thomas Starzl with the 2014 Baruch S. Blumberg Prize for pioneering the first human liver transplant in 1963.

Foundation leaders also will announce the recipients of the 2014 Community Commitment Award, Teri and Jim Holton, of Doylestown. Both have provided generous support to the Hepatitis B Foundation with Teri serving as chair of the Crystal Ball auction committee for the past four years and making it a tremendous success. In addition, Teri volunteers regularly in the community and her church and Jim supports many local food pantries with donations from Kellogg where he is a senior vice president.

The Hepatitis B Foundation is accepting auction items and sponsorship opportunities are still available. For more information regarding the Crystal Ball, call 215-489-4900.

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to http://www.hepb.org, read our blog at http://wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call 215-489-4900.

Contact: Sarah Larson at sarah(at)furiarubel(dot)com or 215-340-0480

Read the full story at http://www.prweb.com/releases/2014/01/prweb11488785.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
2. FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients
3. EU Should Better Prevent Citizens From Hepatitis, Says Liver Patients Organisation ELPA
4. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
5. The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
6. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
7. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
8. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. A Phase IIa Interferon Free Combination Hepatitis C Trial of Simeprevir (TMC435) and TMC647055 Will Commence Shortly
11. Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... , March 22, 2017  Ascendis Pharma ... its innovative TransCon technology to address significant unmet ... results for the full year ended December 31, ... year for our company as we broadened our ... leading, integrated rare disease company with an initial ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... , March 22, 2017   iSpecimen ®, ... that Doctors Pathology Service (DPS), a full-service ... the United States , has joined ... Health Information Network (DHIN) to make human biospecimens ... The novel program, announced in 2015 as a ...
Breaking Biology Technology:
(Date:3/7/2017)... , March 7, 2017 Brandwatch , the ... by The Prince,s Trust to uncover insights to support ... The Trust. The UK,s leading youth charity will be ... campaign results and get a better understanding of the topics and ... ...
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
Breaking Biology News(10 mins):